Search

everythinglearnresearchcommunity

for

Search:↓

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Topical immunotherapy is still effective for managing alopecia areata, even with new treatments available.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Tadalafil and Finasteride may help treat aggressive melanoma.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Fenugreek seeds and Butea monosperma flowers may help reduce hair loss from chemotherapy.

Etanercept effectively treated a severe skin condition when other treatments failed.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Nanoparticles offer significant benefits over traditional chemotherapy for cancer treatment.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Tanshinone IIA helps protect skin tissue from low oxygen damage by boosting certain cell markers.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

A new treatment using gold nanoclusters can safely reduce unwanted hair growth.

Nitrogen mustard was not very effective for hair regrowth in alopecia areata and has potential skin cancer risk.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Aesthetic treatments can safely improve cancer patients' quality of life with oncologist approval.